Identity
HGNC
LOCATION
20q11.23
LOCUSID
ALIAS
C20orf102,dJ1118M15.2
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 128434
MIM: 616537
HGNC: 16096
Ensembl: ENSG00000132821
Variants:
dbSNP: 128434
ClinVar: 128434
TCGA: ENSG00000132821
COSMIC: VSTM2L
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000132821 | ENST00000373459 | Q96N03 |
| ENSG00000132821 | ENST00000373461 | Q96N03 |
| ENSG00000132821 | ENST00000448944 | Q96N03 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37030064 | 2023 | VSTM2L contributes to anoikis resistance and acts as a novel biomarker for metastasis and clinical outcome in ovarian cancer. | 2 |
| 37030064 | 2023 | VSTM2L contributes to anoikis resistance and acts as a novel biomarker for metastasis and clinical outcome in ovarian cancer. | 2 |
| 33506057 | 2021 | High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling. | 9 |
| 33506057 | 2021 | High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling. | 9 |
| 21393573 | 2011 | VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. | 16 |
| 21393573 | 2011 | VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. | 16 |
Citation
Dessen P
VSTM2L (V-set and transmembrane domain containing 2 like)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/75652/vstm2l-(v-set-and-transmembrane-domain-containing-2-like)
